Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

DPH 998.50 +3.50 (0.35%)
price chart
Why I'd Buy GlaxoSmithKline plc Before Dechra Pharmaceuticals plc Or Al Noor ...
For investors in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), the last few years have been very challenging. That's because the company's bottom line has fallen by 17% during the last three years as sales have come under pressure from generic products ...
Are Genus plc And Dechra Pharmaceuticals plc Better Buys Than ...
While shares in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have disappointed in the last year, it has not been the same story for a number of its pharmaceutical rivals. In fact, shares in Genus (LSE: GNS) and Dechra (LSE: DPH) have soared in the last 12 ...
Is AstraZeneca plc A Better Buy Than BTG plc, Dechra Pharmaceuticals plc And ...
Despite being in the midst of coming to terms with the loss of several key, blockbuster drugs, shares in AstraZeneca (LSE: AZN) (NYSE: AZN.
Dechra Pharmaceuticals plc Receives GBX 861.23 Consensus Price Target from ...
Dechra Pharmaceuticals plc logo Shares of Dechra Pharmaceuticals plc (LON:DPH) have earned a consensus rating of “Buy” from the eight analysts that are covering the company, Analyst Ratings Network.
Dechra Pharmaceuticals plc's Buy Rating Reiterated at Shore Capital (DPH)
Shore Capital reissued their buy rating on shares of Dechra Pharmaceuticals plc (LON:DPH) in a research report released on Tuesday morning.
Shore Capital Reaffirms "Hold" Rating for Henderson Group Plc (HGG)  The Legacy
Kier Group plc Given Buy Rating at Westhouse Securities (KIE)  Mideast Time
3 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and ...
However, I'm more interested in BTG and Dechra, which both occupy the FTSE 250 index. Yet BTG is around a ninth the size of Shire, and Dechra is around one thirty eighth the size of Shire, so we can pick from have a good spread of market capitalisations.
Dechra Pharmaceuticals plc Given Consensus Rating of "Buy" by Brokerages ...
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) has received a consensus rating of “Buy” from the eight brokerages that are covering the stock, MarketBeat Ratings reports.
Dechra Pharmaceuticals plc Given Average Rating of "Buy" by Brokerages (LON ...
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) has received an average rating of “Buy” from the eight ratings firms that are covering the company, Market Beat.
Investec Raises Dechra Pharmaceuticals plc Price Target to GBX 1141 (DPH)
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) had its target price lifted by Investec from GBX 980 ($14.87) to GBX 1,141 ($17.32) in a research note released on Tuesday morning.
Dechra Pharmaceuticals plc Given Average Recommendation of "Buy" by ...
Dechra Pharmaceuticals plc logo Shares of Dechra Pharmaceuticals plc (LON:DPH) have received a consensus rating of “Buy” from the eight ratings firms that are covering the stock, Analyst Ratings Network reports.